Abstracts tagged "Psoriatic arthritis and severity"

Abstract Number: 1570 • 2014 ACR/ARHP Annual Meeting
Relationship Between Psoriatic Arthritis Severity, Duration, and Comorbidities
Stacy Tanner¹, Molly McFadden², Daniel Clegg³ and Jessica Walsh⁴, ¹Internal Medicine, University of Utah, Salt Lake City, UT, ²Internal Medicine-Division of Epidemiology, University of Utah, SLC, UT, ³Division of Rheumatology, University of Utah Medical Ctr, Salt Lake City, UT, ⁴Rheumatology Room 4B200 School of Medicine, University of Utah, Salt Lake City, UT
Background/Purpose People with psoriatic arthritis (PsA) have an increased risk for several comorbidities that negatively impact quality of life and survival. Defining the relationships between…
Abstract Number: 624 • 2014 ACR/ARHP Annual Meeting
Genome-Wide Methylome Investigation Reveals New Candidate Genes Associated with Arthritis Mutilans
Vinod Chandran¹, Darren O'Reilly², Amir Haddad¹, Yuhua Zhang³, Guangju Zhai³, Dianne Codner², Arane Thavaneswaran⁴, Proton Rahman^5,6 and Dafna D. Gladman¹, ¹University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Memorial University of Newfoundland, St. John's, NF, Canada, ³Discipline of Genetics, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, ⁴Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁵Rheumatology, St. Claires Mercy Hospital, St. Johns, NF, Canada, ⁶Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada
Background/Purpose Arthritis mutilans is a severe form of psoriatic arthritis (PsA). Why some patients develop this rapidly progressive destructive disease remains unclear. We hypothesized that…
Abstract Number: 351 • 2013 ACR/ARHP Annual Meeting
Psoriatic Arthritis Mutilans: Clinical and Radiographic Definitions. A Systematic Review
Amir Haddad¹, Mansour Somaily², Sindhu R. Johnson³, Rouhi Fazelzad⁴, Amie T. Kron⁵, Cathy Chau⁶ and Vinod Chandran⁷, ¹Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Medicine, Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³Medicine, Toronto Scleroderma Program, Toronto Western Hospital, Toronto General Hospital, Mount Sinai Hospital, and University of Toronto, Toronto, ON, Canada, ⁴Health Sciences Libraries - Toronto General Hospital, University Health Network, Toronto, ON, Canada, ⁵Medicine, Toronto Scleroderma Program, Toronto Western Hospital, Mount Sinai Hospital, and University of Toronto, Toronto, ON, Canada, ⁶Medicine, Toronto Scleroderma Program, Toronto Western Hospital, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ⁷Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: Psoriatic Arthritis Mutilans (PAM) is the most severe form of psoriatic arthritis. Research on PAM has been impeded by the lack of an accepted…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].